SE(R)RS has been used in a variety of applications, including label-free analysis for the diagnosis of prostate cancer [8], the detection of prostate-specific antigen using SERS in a microfluidic device [9] (Figure 3B) and for prostate cancer disease stratification (Figure 3C) [10]. This evidence concerns the gene KLK3 and prostate carcinoma.